We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Immupharma Plc | LSE:IMM | London | Ordinary Share | GB0033711010 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.14 | -6.86% | 1.90 | 1.84 | 1.96 | 2.01 | 2.00 | 2.00 | 1,925,128 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.81M | -0.0114 | -1.76 | 6.7M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/6/2018 16:24 | Failed Phase 3. Bubble bursting. | ken chung | |
25/6/2018 14:44 | So all the rampers have zero belief that this will get over 27.5p today never mind 30p. Not one of them has taken me up on my wager offer, tells the truth of their story doesn't it. | 1retirement | |
25/6/2018 09:43 | Come on Kirky et al, don't be shy. Should be easy money if you take my wager AND you truly believe this will get over 27.5p never mind 30p. Come out come out wherever you are?! | 1retirement | |
25/6/2018 08:59 | Watch out for the bloodbath today. | teddy boy1 | |
25/6/2018 08:49 | PS I see the price is racing towards 30p.... | nobbygnome | |
25/6/2018 08:48 | s_k was a very well respected poster here and indeed author of this thread so it is relevant to post the information here! | nobbygnome | |
25/6/2018 08:44 | Make sure you click to get your last hundred points only a couple of thousand left about to end stop Free 100+1 coins just one click away!!!! ++++++++++++++++++++ ++++++++++++++++++++ | football | |
25/6/2018 08:31 | Interesting post from sicilian_kan on the VAL thread this morning..... | nobbygnome | |
25/6/2018 08:10 | Categorically state I do not have a short in this company. | 1retirement | |
25/6/2018 08:02 | I can categorically deny I don't have a short in this company. Now, where are those confident rampers willing to take my challenge. If you're so confident it will hit 30p today then take up the bet. Hell, lets make it interesting I say it won't hit 27.5p and I'll set the bet at that level. Bound to be easy money for you Kirk et al?! | 1retirement | |
25/6/2018 07:14 | There is no placebo group in the extension study so it is only of any use from a safety point of view. And let's face it, safety is not the problem, efficacy is! | nobbygnome | |
25/6/2018 07:00 | They only managed to get 44 patients into the extension study so it won't be statistically significant and will not report until 2019. | ken chung | |
25/6/2018 06:35 | Great things to come here......the only way is up imho | cudmore | |
24/6/2018 23:54 | Seems like they're worried to me, seems uncharacteristic for them to post this time of the evening. If he dies, he dies. | a_2_b | |
24/6/2018 23:16 | So why bother wasting time on this board if your not invested .... thats right u have a short.... that's why your on this board to de ramp the company . | rakepat37 | |
24/6/2018 23:14 | Gamblers and fools now. | ken chung | |
24/6/2018 21:59 | I don't think there is any ambiguity that this will hit 30p next week. No one is even arguing with this now. People have moved on and are now looking for 40p | kirk 6 | |
24/6/2018 20:53 | What about those that went in to full remission? Didn't mention them did you, very convenient, you are so transparent "Chung" gnome lol | brad44 | |
24/6/2018 20:46 | Agreed this will fly tomorrow! I'm expecting a surge through 30p any day now | kirk 6 | |
24/6/2018 20:40 | As far as I can see Lupuzor failed to meet the Phase 3 primary endpoints because that is clearly what the announcement in April says. There was also a shockingly high drop out rate even among people taking the drug. The sub-group in which the company says it performed least badly was unfortunately not sufficiently large and by a sufficiently large margin to achieve statistical significance. To be honest it seems similar to placebo + standard of care, so it would be cheaper just to prescribe good care to patients. At best it will need another Phase 3 trial which means millions more cash will need to be raised and a lot more time expended. Meanwhile there is nothing else to bring to market. Sorry but that is how it is. | ken chung | |
24/6/2018 19:56 | This is going to blow big time, this has to be the bargain of a century. Seriously low shares In issue and partners news or buy out on the way with a re rate ... | rakepat37 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions